Usе of plant-based drugs in the treatment of nonalcoholic fatty liver disease and obesity

Abstract

The incidence of hepatobiliary system diseases, in particular – nonalcoholic fatty liver disease (NAFLD) based on metabolic syndrome, has been increasing in the developing countries of the world in the last decade. As а rule, these situations cause the phenomenon of polypragmasy (polypharmacy) to build the full-fledged treatment complex, which, in turn, leads to the risk of side effects and complications, especially while using synthetic drugs. Therefore, current trends in drug therapy, especially in cases of multicomponent pathology, require the inclusion of medicines in complex treatment, which have а wide range of adjustive properties and are characterized by softness, the gradualism of action, including minimal side effects or their absence. Plant-based preparations meet these requirements.